SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Rocanin-Arjo, W. Cohen, L. Carcaillon, C. Frere, N. Saut, L. Letenneur, M. Alhenc-Gelas, A.-M. Dupuy, M. Bertrand, M.-C. Alessi, M. Germain, P. S. Wild, T. Zeller, F. Cambien, A. H. Goodall, P. Amouyel, P.-Y. Scarabin, D.-A. Tregouet, P.-E. Morange, A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential, Blood, 2014, 123, 5, 777

    CrossRef

  2. 2
    Paolo Prandoni, Sofia Barbar, Marta Milan, Valentina Vedovetto, Raffaele Pesavento, The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities, European Journal of Internal Medicine, 2014, 25, 1, 25

    CrossRef

  3. 3
    Siti K. Ismail, Lucy Norris, Susan O’Shea, John R. Higgins, Weight-adjusted LMWH Prophylaxis Provides More Effective Thrombin Inhibition in Morbidly Obese Pregnant Women, Thrombosis Research, 2014,

    CrossRef

  4. 4
    Lara N. Roberts, Raj K. Patel, Paradzai Chitongo, Lynda Bonner, Roopen Arya, African–Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation, Blood Coagulation & Fibrinolysis, 2013, 24, 1, 40

    CrossRef

  5. 5
    Y. Dargaud, M. Hoffman, L. Lefrapper, F.-C. Lin, A. Genty, B. Chatard, S. Marin, C. Négrier, D. M. Monroe, Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels, Journal of Thrombosis and Haemostasis, 2013, 11, 6
  6. 6
    Susan V. Mallett, Pratima Chowdary, Andrew K. Burroughs, Clinical utility of viscoelastic tests of coagulation in patients with liver disease, Liver International, 2013, 33, 7
  7. 7
    O. Segers, P. Simioni, D. Tormene, E. Castoldi, Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes, Thrombosis and Haemostasis, 2013, 111, 3, 438

    CrossRef

  8. 8
    Roza Chaireti, Cecilia Jennersjö, Tomas L. Lindahl, Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up, Thrombosis Research, 2013, 131, 2, 135

    CrossRef

  9. 9
    Maura Marcucci, Alfonso Iorio, James Douketis, Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach, Current Treatment Options in Cardiovascular Medicine, 2013, 15, 2, 224

    CrossRef

  10. 10
    Kristina Sonnevi, Svetlana N. Tchaikovski, Margareta Holmström, Jovan P. Antovic, Katarina Bremme, Jan Rosing, Gerd Lärfars, Obesity and thrombin-generation profiles in women with venous thromboembolism, Blood Coagulation & Fibrinolysis, 2013, 24, 5, 547

    CrossRef

  11. 11
    P. A. Kyrle, L. Eischer, Predicting the risk of recurrent venous thromboembolism, Hämostaseologie, 2013, 33, 3

    CrossRef

  12. You have free access to this content12
    S. C. Cannegieter, A. Hylckama Vlieg, Venous thrombosis: understanding the paradoxes of recurrence, Journal of Thrombosis and Haemostasis, 2013, 11,
  13. 13
    A. TRIPODI, V. CHANTARANGKUL, M. E. MANCUSO, L. LEMMA, M. CLERICI, E. SANTAGOSTINO, Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents, Journal of Thrombosis and Haemostasis, 2012, 10, 4
  14. 14
    Yesim Dargaud, Alisa S. Wolberg, Roger Luddington, Veronique Regnault, Henri Spronk, Trevor Baglin, Thomas Lecompte, Hugo Ten Cate, Claude Negrier, Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study, Thrombosis Research, 2012, 130, 6, 929

    CrossRef

  15. 15
    Vicky Tagalakis, Dimple Kondal, Yunqi Ji, Jean-Francois Boivin, Yola Moride, Antonio Ciampi, Susan R. Kahn, Men had a Higher Risk of Recurrent Venous Thromboembolism than Women: A Large Population Study, Gender Medicine, 2012, 9, 1, 33

    CrossRef

  16. 16
    Christopher Bombardier, Elizabeth Villalobos-Menuey, Katherine Ruegg, William E. Hathaway, Marilyn J. Manco-Johnson, Neil A. Goldenberg, Monitoring hypercoagulability and hypofibrinolysis following acute venous Thromboembolism in Children: Application of the CloFAL assay in a prospective inception cohort study, Thrombosis Research, 2012, 130, 3, 343

    CrossRef

  17. 17
    J.K. Ryland, A.S. Lawrie, I.J. Mackie, S.J. Machin, Persistent high factor VIII activity leading to increased thrombin generation – A prospective cohort study, Thrombosis Research, 2012, 129, 4, 447

    CrossRef

  18. 18
    Katerina Lejhancova-Tousovska, Ondrej Zapletal, Sona Vytiskova, Petra Strbackova, Jaroslav Sterba, Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin–Frankfurt–Münster (BFM) protocols, Blood Coagulation & Fibrinolysis, 2012, 23, 2, 144

    CrossRef

  19. 19
    Hugo ten Cate, Thrombin generation in clinical conditions, Thrombosis Research, 2012, 129, 3, 367

    CrossRef

  20. 20
    Raed Al Dieri, Bas de Laat, H. Coenraad Hemker, Thrombin generation: What have we learned?, Blood Reviews, 2012, 26, 5, 197

    CrossRef

  21. 21
    Michael A. Laffan, Richard Manning, Dacie and Lewis Practical Haematology, 2012,

    CrossRef

  22. 22
    Fred J. L. M. Haas, Roger E. G. Schutgens, Cornelis Kluft, Douwe H. Biesma, A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly, Scandinavian Journal of Clinical & Laboratory Investigation, 2011, 71, 1, 12

    CrossRef

  23. 23
    Armando Tripodi, Adriana Branchi, Veena Chantarangkul, Marigrazia Clerici, Giuliana Merati, Andrea Artoni, Pier Mannuccio Mannucci, Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay, Journal of Thrombosis and Thrombolysis, 2011, 31, 2, 165

    CrossRef

  24. 24
    Fred J.L.M. Haas, Cornelis Kluft, Douwe H. Biesma, Roger E.G. Schutgens, Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay, Blood Coagulation & Fibrinolysis, 2011, 22, 6, 506

    CrossRef

  25. 25
    B.A.L. Owen, A. Xue, J.A. Heit, W.G. Owen, Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism, Thrombosis Research, 2011, 127, 1, 39

    CrossRef

  26. 26
    Astrid Bergrem, Anders Erik Astrup Dahm, Anne Flem Jacobsen, Marie-Christine Mowinckel, Leiv Sandvik, Per Morten Sandset, Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism, British Journal of Haematology, 2011, 154, 2
  27. 27
    H. G. WATSON, RVO – Real value obscure, Journal of Thrombosis and Haemostasis, 2011, 9, 6
  28. 28
    Roberto Marchioli, Guido Finazzi, Giorgina Specchia, Arianna Masciulli, Maria Rosaria Mennitto, Tiziano Barbui, The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera, Thrombosis, 2011, 2011, 1

    CrossRef

  29. 29
    Heike Bernhard, Andrea Deutschmann, Bettina Leschnik, Sabrina Schweintzger, Michael Novak, Almuthe Hauer, Wolfgang Muntean, Thrombin generation in pediatric patients with Crohn's disease, Inflammatory Bowel Diseases, 2011, 17, 11
  30. 30
    Elisabetta Castoldi, Jan Rosing, Thrombin generation tests, Thrombosis Research, 2011, 127, S21

    CrossRef

  31. 31
    TREVOR BAGLIN, Using the laboratory to predict recurrent venous thrombosis, International Journal of Laboratory Hematology, 2011, 33, 4
  32. 32
    Armando Tripodi, Cristina Legnani, Laura Lemma, Benilde Cosmi, Gualtiero Palareti, Veena Chantarangkul, Pier Mannuccio Mannucci, Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism, Journal of Thrombosis and Thrombolysis, 2010, 30, 2, 215

    CrossRef

  33. 33
    Giuseppe Lippi, Gianfranco Cervellin, Massimo Franchini, Emmanuel J. Favaloro, Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future, Journal of Thrombosis and Thrombolysis, 2010, 30, 4, 459

    CrossRef

  34. 34
    M. Wilkens, Endogenous thrombin potential in practical use, Hämostaseologie, 2010, 31, 2, 88

    CrossRef

  35. 35
    A. GATT, A. RIDDELL, V. CALVARUSO, E. G. TUDDENHAM, M. MAKRIS, A. K. BURROUGHS, Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy, Journal of Thrombosis and Haemostasis, 2010, 8, 9
  36. 36
    M. ALHENC-GELAS, M. CANONICO, V. PICARD, Influence of natural SERPINC1 mutations on ex vivo thrombin generation, Journal of Thrombosis and Haemostasis, 2010, 8, 4
  37. 37
    Clive Kearon, Long-term Anticoagulation for Venous Thromboembolism: Duration of Treatment and Management of Warfarin Therapy, Clinics in Chest Medicine, 2010, 31, 4, 719

    CrossRef

  38. 38
    Gregor Hron, Paul A. Kyrle, Alexandra Kaider, Karl Philipp, Ingrid Pabinger, Marietta Kollars, Sabine Eichinger, ProCGlobal and endogenous thrombin potential during pregnancy, American Journal of Obstetrics and Gynecology, 2010, 203, 5, 463.e1

    CrossRef

  39. 39
    Paul Alexander Kyrle, Frits R Rosendaal, Sabine Eichinger, Risk assessment for recurrent venous thrombosis, The Lancet, 2010, 376, 9757, 2032

    CrossRef

  40. 40
    Y. Dargaud, R. Luddington, E. Gray, T. Lecompte, T. Siegemund, T. Baglin, J. Hogwood, V. Regnault, A. Siegemund, C. Negrier, Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study, Thrombosis Research, 2010, 125, 4, 353

    CrossRef

  41. You have free access to this content41
    S. C. NAIR, Y. DARGAUD, M. CHITLUR, A. SRIVASTAVA, Tests of global haemostasis and their applications in bleeding disorders, Haemophilia, 2010, 16,
  42. 42
    T. BAGLIN, Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic state, Journal of Thrombosis and Haemostasis, 2010, 8, 2
  43. 43
    S. EICHINGER, P. A. KYRLE, Duration of anticoagulation after initial idiopathic venous thrombosis – the swinging pendulum: Risk assessment to predict recurrence, Journal of Thrombosis and Haemostasis, 2009, 7,
  44. 44
    Y. Buyue, J. P. Sheehan, Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite, Blood, 2009, 114, 14, 3092

    CrossRef

  45. 45
    Catherine N. Bagot, Roopen Arya, Is ‘Virchow’s triad’ useful? – response to Malone and Agutter, British Journal of Haematology, 2009, 145, 6
  46. 46
    K. Kuczka, K. Baum, B. Picard-Willems, S. Harder, Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients, Thrombosis Research, 2009, 124, 5, 625

    CrossRef

  47. 47
    A. TRIPODI, C. LEGNANI, G. PALARETI, V. CHANTARANGKUL, P. M. MANNUCCI, More on: high thrombin generation and the risk of recurrent venous thromboembolism, Journal of Thrombosis and Haemostasis, 2009, 7, 5
  48. 48
    P. L. LUTSEY, A. R. FOLSOM, S. R. HECKBERT, M. CUSHMAN, Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study, Journal of Thrombosis and Haemostasis, 2009, 7, 10
  49. 49
    K. MEIJER, S. SCHULMAN, The absence of `minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios, Journal of Thrombosis and Haemostasis, 2009, 7, 10
  50. 50
    Jeffrey I. Weitz, Unanswered questions in venous thromboembolism, Thrombosis Research, 2009, 123, S2

    CrossRef

  51. 51
    Trevor Baglin, Heritable Thrombophilia,